Hyperbaric oxygen pre-breathe modifies the outcome of decompression sickness

Undersea and Hyperbaric Medicine

Volumn 33, Issue 6, 2006, Pages 407-417

  Butler, B D ^a   Little, T ^a   Cogan, V ^a   Powell, M ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NASA JOHNSON SPACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEUKOTRIENE E4; NITRIC OXIDE; PROTEIN; THROMBOXANE B2;

ANIMAL; ARTICLE; BLOOD; DECOMPRESSION; DECOMPRESSION SICKNESS; EVALUATION; HYPERBARIC OXYGEN; LEUKOCYTE COUNT; LUNG; LUNG EDEMA; LUNG LAVAGE; MALE; METHODOLOGY; ORGAN SIZE; PATHOLOGY; PLEURA; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; DECOMPRESSION; DECOMPRESSION SICKNESS; HYPERBARIC OXYGENATION; LEUKOCYTE COUNT; LEUKOTRIENE E4; LUNG; MALE; NITRIC OXIDE; ORGAN SIZE; PLEURA; PROTEINS; PULMONARY EDEMA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2;

EID: 33847057291     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Elliot DH, Moon RE. Manifestations of the decompression disorders. In: Bennett P, Elliot D. eds. The physiology and medicine of diving, 4th ed. London: WB Saunders, 1993:480-505.
2. Butler BD, Robinson R, Little T, Chelly JE, Doursout M-F. Cardiopulmonary changes with moderate decompression in rats. Undersea Hyperb Med 1996; 23:83-89.
3. Philp RB. A review of blood changes associated with compression- decompression: relationship to decompression sickness. Undersea Biomed Res 1974; 1:117-150.
4. Albertine KH, Gee MH, Peters SP, Rosolia DL. Activation responses of sheep neutrophils in vivo are comparable to activation responses in vitro. FASEB J 1991; 5:A1271.
5. Worthen GS, Schwab B III, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 1989; 245: 183-186.
6. Butler BD, Little T. Effects of venous air embolism and decompression on thromboxane and leukotriene levels in dogs. Undersea Hyperb Med 1994; 21 (suppl):21-22.
7. Little T, Butler BD. Dibutyryl cAMP effects on thromboxane and leukotriene production in decompression-induced lung injury. Undersea Hyperb Med 1997; 24(3): 185-191.
8. Miller JD, Fitch W, Ledingham IM, Jennett WB. The effect of hyperbaric oxygen on experimentally increased intracranial pressure. J Neurosurg 1970; 33(3):287-296.
9. Nylander G, Lewis D, Nordstrom H, Larsson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 1985; 76(4):596- 603.
10. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke 1995; 26:2307-2312.
11. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993; 91(6): 1110-1123.
12. Thom SR, Mendiguren I, Hardy K, Bolotin T, Fisher D, Nebolon M, Kilpatrick L. Inhibition of human neutrophil ß2-integrin-dependent adherence by hyperbaric 02. Am J Physiol 1997; 272(3 Pt 1): C770-777.
13. Behnke AR. The application of measurements of nitrogen elimination to the problem of decompressing divers. U.S. Naval Med Bull 1937; 35:219-240.
14. Ferris EB, Webb JP, Ryder HW, et al. The protective value of preflight oxygen inhalation at rest decompression sickness. Washington, DC: Division of Medical Sciences, National Research Council, Acting for the Committee on Medical Research of the Office of Scientific Research and Development; Comm Aviat Med Report #132, 1943; pp 8.
15. Fryer DI. Subatmospheric Decompression Sickness in Man. Pub. Technivision Services, Slough, England, 1969: Chapter 12:259-276.
16. Waligora JM, Horrigan DJ, Conkin J, Hadley AT III. Verification of an altitude decompression sickness prevention protocol for shuttle operations utilizing a 10.2 PSI pressure stage. Johnson Space Center, Houston, TX: NASA TM 58259 (NTIS #N84-28392), 1984; 58.
17. Webb JT, Fischer MD, Heaps CL, Pilmanis AA. Exercise-enhanced prebreathing increases protection from decompression. Aviat Space Environ Med 1996; 67:618-624.
18. Soelting,TK. Endotracheal Intubation. In: Miller, RD ed., Anesthesia, 2nd ed., Vol. 1. London: Churchill Livingstone, 1986: 527.
19. Wada K, Ito M, Miyazawa T, Katoh H, Nawashiro H, Shima K, Chigasaki H. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res 1996; 740(1-2): 15-20.
20. Xiong L, Zhu Z, Dong H, Hu W, Hou L, Chen S. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model. Chin Med J (Engl) 2000; 113(9):836-839.
21. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology 2002; 96(4):907-912.
22. Skogland S, Stuhr LEB, Sundland H, Marstein S, Hope A. Increased oxygen before and during decompression reduces bubble formation in rats. Undersea Hyperb Med 2003; 30(l):37-46.
23. Lillo RS, Parker, EC. Mixed-gas model for predicting decompression sickness in rats. J Appl Physiol 2000; 89:2107-2116.
24. Vestergaard P, Leverett R. Constancy of urinary creatinine excretion. J Biol Chem 1958; 51:211-218.
25. Wiener-Kronish JP,Broaddus VC. Interrelationship of pleural and pulmonary interstitial liquid. Ann. Rev Physiol 1993; 55:209-226. Review.
26. Pearce M, Yamashita J, Beazell J. Measurement of pulmonary edema. Cire Res 1965; 16:483-488.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
28. Butler BD, Little T, Fife C, Williford D, Thom SR, Martin J. Hyperbaric oxygen pre-breathe (HBOP) effects on decompression. Undersea Hyperb Med 2001; 28 (supp):46.
29. Sourtiere SE, Temple DJ, Johnson TO, Nelson JW. Oxygen pre-breathe is an effective non-recompressive strategy for disabled submarine rescue. Undersea Hyperb Med 2005; 32(4):228-229.
30. Landolfi A, Faralli F, Camporesi EM, Yang ZJ, Savini F, Bosco G. Hyperbaric oxygen pretreatment reduces decompression induced air bubble formation and platelets activation. Undersea Hyperb Med 2005; 32(4):227-228.
31. Martin JD, Thom SR. Effects of hyperbaric oxygen pre-treatment on neurologic outcome and leukocyte sequestration as a consequence of decompression stress. Undersea Hyperb Med 2000; 27(supp): 19.
32. Martin JD, Thom SR. Vascular leukocyte sequestration in decompression sickness and prophylactic hyperbaric oxygen therapy in rats. Aviat Space Environ Med 2002; 73(6):565-569.
33. Bove AA, Hallenbeck JM, Elliott DH. Circulatory responses to venous air embolism and decompression sickness in dogs. Undersea Biomed Res 1974; 1:207-220.
34. Catron PW, Flynn ET, Yaffe L, et. al. Morphological and physiological responses of the lungs of dogs to acute decompression. J Appl Physiol 1984; 57:467-474.
35. Flick MR, Perel A, Staub NC. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ Res 1981; 48:344-351.
36. Albertine KH, Wiener-Kronish JP, Koike K, Staub NC. Quantification of damage by air emboli to lung microvessels in anesthetized sheep. J Appl Physiol 1984; 57:1360-1368.
37. Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 1993; 123(2):248-256.
38. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstruct Surg 1993; 91(6): 1110-1123.
39. Bonsignore MR, Rice TR, Dodek PM, Staub NC. Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep. Microcirc Endothelium Lymphatics 1986; 3:187-212.
40. Patel JP, Beck LD, Briglia FA, Hock CE. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock. Crit Care Med 1995; 23:231-237.
41. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72:2994-2998.
42. Granström E, Kumlin M. Assay of thromboxane production in biological systems: Reliability of TxB2 versus 11-dehydro-TxB2 for measurement. Adv Prostaglandin Thromboxane Leukotriene Res 1987; 17:587-594.
43. Reinke M. Monitoring thromboxane in body fluids: A specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. Am J Physiol 1992; 25:E658-E662.
44. Voelkel NF, Worthen S, Reeves JT, Henson PM, Murphy RC. Nonimmunological production of leukotrienes induced by platelet-activating factor. Science 1982; 218(4569):286-289.
45. Hua XY, Dahlen SE, Lundberg JM, Hammarstrom S, Hedqvist P. Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1985; 330(2): 136-141.
46. Reeves JT, Stenmark KR, Voelkel NF. Possible role of leukotrienes in the pathogenesis of pulmonary hypertensive disorders. In: Said SE ed. The Pulmonary and Acute Lung Injury. Mount Kisco, NY: Futura Pub., 1985: 337-356.
47. Bernard GR, Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Persistant generation of peptide leukotrienes in patients with the adult respiratory distress syndrome. Am Rev Resp Dis 1991; 144:263-267.
48. Snapper JR, Coggeshall JW, Serafin WE, Phillips MA, Lefferts PL, Christman BW. Role of leukotrienes in an animal model of the adult respiratory distress syndrome. Adv Prostaglandin, Thromboxane Leukotriene Res 1987; 17:1043-1046.
49. MacGlashan DW Jr, Schleimer RP, Peters SP, Schulman ES, Adams GK 3rd, Newball HH, Lichtenstein LM. Generation of leukotrienes by purified human lung mast cells. J Clin Invest 1982; 70(4):747-751.
50. Weller PF, Lee CW, Foster DW, Corey EJ, Austen KF, Lewis RA. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983; 80(24):7626-7630.
51. Lagarde M, Gualde N, Rigaud M. Metabolic interactions between eicosanoids in blood and vascular cells. Biochem J 1989; 257:313-320.